Marco Feri

2.6k total citations
11 papers, 165 citations indexed

About

Marco Feri is a scholar working on Infectious Diseases, Neurology and Oncology. According to data from OpenAlex, Marco Feri has authored 11 papers receiving a total of 165 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Neurology and 3 papers in Oncology. Recurrent topics in Marco Feri's work include COVID-19 Clinical Research Studies (3 papers), Organ Donation and Transplantation (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). Marco Feri is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Organ Donation and Transplantation (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). Marco Feri collaborates with scholars based in Italy. Marco Feri's co-authors include Di Filippo A, Rosario Spina, Angelo Raffaele De Gaudio, Maria Lorubbio, Danilo Tacconi, Agostino Ognibene, Raffaele Scala, Alessandro Pancrazzi, Raffaella Pavani and Fabio Sangalli and has published in prestigious journals such as Critical Care Medicine, Clinica Chimica Acta and Clinical Biochemistry.

In The Last Decade

Marco Feri

11 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Feri Italy 5 52 51 48 41 38 11 165
Suprava Naik India 7 31 0.6× 18 0.4× 48 1.0× 69 1.7× 48 1.3× 78 215
Gökhan Ceylan Türkiye 8 13 0.3× 45 0.9× 19 0.4× 21 0.5× 14 0.4× 37 165
Karam R. Motawea Egypt 8 15 0.3× 40 0.8× 14 0.3× 30 0.7× 18 0.5× 50 172
Amirhossein Roshanshad Iran 9 27 0.5× 31 0.6× 48 1.0× 28 0.7× 28 0.7× 24 219
Simon Calle Belgium 11 30 0.6× 48 0.9× 5 0.1× 83 2.0× 37 1.0× 34 350
Waiel Abusnina United States 9 9 0.2× 54 1.1× 16 0.3× 67 1.6× 29 0.8× 83 269
Shlomi Toussia‐Cohen Israel 8 17 0.3× 21 0.4× 61 1.3× 22 0.5× 30 0.8× 21 248
Uddalak Chakraborty India 9 143 2.8× 42 0.8× 20 0.4× 24 0.6× 150 3.9× 59 319
Elena Zoia Italy 8 9 0.2× 31 0.6× 21 0.4× 72 1.8× 50 1.3× 25 199
Christine Collienne Belgium 7 42 0.8× 23 0.5× 67 1.4× 127 3.1× 55 1.4× 15 293

Countries citing papers authored by Marco Feri

Since Specialization
Citations

This map shows the geographic impact of Marco Feri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Feri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Feri more than expected).

Fields of papers citing papers by Marco Feri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Feri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Feri. The network helps show where Marco Feri may publish in the future.

Co-authorship network of co-authors of Marco Feri

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Feri. A scholar is included among the top collaborators of Marco Feri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Feri. Marco Feri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lorubbio, Maria, et al.. (2022). The role of Monocyte Distribution Width (MDW) in the prognosis and monitoring of COVID-19 patients. Clinical Biochemistry. 103. 29–31. 22 indexed citations
2.
Pavani, Raffaella, et al.. (2021). Successful use of CytoSorb in a Covid-19 patient with secondary septic shock due to a sacral decubitus infection. The International Journal of Artificial Organs. 44(12). 1034–1038. 2 indexed citations
3.
Pieroni, Maurizio, et al.. (2021). Cytosorb treatment in severe COVID-19 cardiac and pulmonary disease. European Heart Journal - Case Reports. 5(4). ytab123–ytab123. 1 indexed citations
4.
Ognibene, Agostino, Maria Lorubbio, Marco Feri, et al.. (2020). Elevated monocyte distribution width in COVID-19 patients: The contribution of the novel sepsis indicator. Clinica Chimica Acta. 509. 22–24. 37 indexed citations
5.
Sangalli, Fabio, Giacomo Bellani, Marco Feri, et al.. (2020). Levosimendan to facilitate weaning from cardiorespiratory support in critically ill patients: current evidence and future directions. Minerva Anestesiologica. 86(6). 645–651. 6 indexed citations
6.
Mura, Gianni, Francesca Tauceri, Marco Feri, & Giorgio Maria Verdecchia. (2011). Report of two cases of Castleman's Disease: a case of benign localized disease and a case of fast progressive multicentric disease.. PubMed. 82(1). 77–81. 1 indexed citations
7.
Gaudio, Angelo Raffaele De, Rosario Spina, Di Filippo A, & Marco Feri. (1999). Glomerular permeability and trauma: A correlation between microalbuminuria and Injury Severity Score. Critical Care Medicine. 27(10). 2105–2108. 35 indexed citations
8.
Mori, Marco, et al.. (1995). [Potential organ donors at an Italian intensive care unit].. PubMed. 61(3). 63–9. 1 indexed citations
9.
Feri, Marco, et al.. (1994). Transcranial Doppler and brain death diagnosis. Critical Care Medicine. 22(7). 1120–1126. 56 indexed citations
10.
Romagnoli, Paolo, et al.. (1992). [Tetanus disease. Experience with 2 intensive treatments during 13 years].. PubMed. 58(4). 165–72. 3 indexed citations
11.
Tulli, G, et al.. (1989). [Multiple organ failure syndrome in infection caused by ictero-hemorragic Leptospira. Description of a clinical case].. PubMed. 55(10). 423–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026